MAKO Surgical (NASDAQ:MAKO) made an appearance at the Piper Jaffray investor conference this week, partially in order to address some investor concerns about why the company needed to raise capital now, and why it decided to tap the equity markets versus using its available credit line with Deerfield Capital Management. In this video, Motley Fool health care analyst Brenton Flynn discusses what MAKO said about those points, and he highlights a few other interesting tidbits from the conference presentation and question-and-answer sessions.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/20/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.